A Cockayne-like phenotype resulting from a de novo variant in MORC2: expanding the phenotype of MORC2-related disorders

Amytice Mirchi; Alexa Derksen; Luan T. Tran; Isabelle De Bie; Amélie Nadeau; Audrey Lovett; Anja Raams; Wim Vermeulen; Arjan F. Theil; Geneviève Bernard

doi:10.1007/s10048-022-00697-2

A Cockayne-like phenotype resulting from a de novo variant in MORC2: expanding the phenotype of MORC2-related disorders

Amytice Mirchi, Alexa Derksen, Luan T. Tran, Isabelle De Bie, Amélie Nadeau, Audrey Lovett, Anja Raams, Wim Vermeulen, Arjan F. Theil, Geneviève Bernard^*

^*Corresponding author for this work

Molecular Genetics

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Abstract

Cockayne syndrome is a rare inherited DNA repair multisystemic disorder. Here, we aim to raise awareness of the phenotypic resemblances between Cockayne syndrome and the neurodevelopmental disorder caused by pathogenic variants in MORC2, a gene also involved in DNA repair. Using exome sequencing, we identified a de novo pathogenic variant in MORC2 in our patient. Our patient’s phenotype was characterized by multiple features evocative of Cockayne syndrome. Based on our patient’s phenotype, in addition to the phenotypic description of patients with pathogenic variants in MORC2 reported in the literature, we suggest that pathogenic variants in this gene are associated with a Cockayne-like phenotype.

Original language	English
Pages (from-to)	271-274
Number of pages	4
Journal	Neurogenetics
Volume	23
Issue number	4
Early online date	3 Aug 2022
DOIs	https://doi.org/10.1007/s10048-022-00697-2
Publication status	Published - Oct 2022

Bibliographical note

Funding Information:
This study was funded by grants from the Canadian Institutes of Health Research (377869 and 426534). This research was enabled in part by support provided by Compute Canada ( www.computecanada.ca ). The authors also wish to acknowledge the McGill University and Genome Quebec Innovation Center. A. Derksen is supported by the Canadian Institutes of Health Research (CIHR) Canadian Graduates Scholarships - Master’s, the Fondation du Grand Defi Pierre Lavoie Master’s Scholarship, and Heathy Brains for Healthy Lives Master’s Fellowship. G. Bernard has received the Clinical Research Scholar Junior 1 award from the Fonds de Recherche du Quebec - Santé (FRQS) (2012–2016), the New Investigator Salary Award from the CIHR (2017–2022) and the Clinical Research Scholar Senior award from the FRQS (2022–2025). W. Vermeulen, A.F. Theil, and A. Raams are supported by grants from European Research Council Advanced grant (340988) and Oncode Institute (partly financed by the Dutch Cancer Society).

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Access to Document

10.1007/s10048-022-00697-2

Cite this

@article{fb0e013877c543599b50404b096b26cc,

title = "A Cockayne-like phenotype resulting from a de novo variant in MORC2: expanding the phenotype of MORC2-related disorders",

abstract = "Cockayne syndrome is a rare inherited DNA repair multisystemic disorder. Here, we aim to raise awareness of the phenotypic resemblances between Cockayne syndrome and the neurodevelopmental disorder caused by pathogenic variants in MORC2, a gene also involved in DNA repair. Using exome sequencing, we identified a de novo pathogenic variant in MORC2 in our patient. Our patient{\textquoteright}s phenotype was characterized by multiple features evocative of Cockayne syndrome. Based on our patient{\textquoteright}s phenotype, in addition to the phenotypic description of patients with pathogenic variants in MORC2 reported in the literature, we suggest that pathogenic variants in this gene are associated with a Cockayne-like phenotype.",

author = "Amytice Mirchi and Alexa Derksen and Tran, {Luan T.} and {De Bie}, Isabelle and Am{\'e}lie Nadeau and Audrey Lovett and Anja Raams and Wim Vermeulen and Theil, {Arjan F.} and Genevi{\`e}ve Bernard",

note = "Funding Information: This study was funded by grants from the Canadian Institutes of Health Research (377869 and 426534). This research was enabled in part by support provided by Compute Canada ( www.computecanada.ca ). The authors also wish to acknowledge the McGill University and Genome Quebec Innovation Center. A. Derksen is supported by the Canadian Institutes of Health Research (CIHR) Canadian Graduates Scholarships - Master{\textquoteright}s, the Fondation du Grand Defi Pierre Lavoie Master{\textquoteright}s Scholarship, and Heathy Brains for Healthy Lives Master{\textquoteright}s Fellowship. G. Bernard has received the Clinical Research Scholar Junior 1 award from the Fonds de Recherche du Quebec - Sant{\'e} (FRQS) (2012–2016), the New Investigator Salary Award from the CIHR (2017–2022) and the Clinical Research Scholar Senior award from the FRQS (2022–2025). W. Vermeulen, A.F. Theil, and A. Raams are supported by grants from European Research Council Advanced grant (340988) and Oncode Institute (partly financed by the Dutch Cancer Society). Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2022",

month = oct,

doi = "10.1007/s10048-022-00697-2",

language = "English",

volume = "23",

pages = "271--274",

journal = "Neurogenetics",

issn = "1364-6745",

publisher = "Springer Science+Business Media",

number = "4",

}

TY - JOUR

T1 - A Cockayne-like phenotype resulting from a de novo variant in MORC2

T2 - expanding the phenotype of MORC2-related disorders

AU - Mirchi, Amytice

AU - Derksen, Alexa

AU - Tran, Luan T.

AU - De Bie, Isabelle

AU - Nadeau, Amélie

AU - Lovett, Audrey

AU - Raams, Anja

AU - Vermeulen, Wim

AU - Theil, Arjan F.

AU - Bernard, Geneviève

N1 - Funding Information: This study was funded by grants from the Canadian Institutes of Health Research (377869 and 426534). This research was enabled in part by support provided by Compute Canada ( www.computecanada.ca ). The authors also wish to acknowledge the McGill University and Genome Quebec Innovation Center. A. Derksen is supported by the Canadian Institutes of Health Research (CIHR) Canadian Graduates Scholarships - Master’s, the Fondation du Grand Defi Pierre Lavoie Master’s Scholarship, and Heathy Brains for Healthy Lives Master’s Fellowship. G. Bernard has received the Clinical Research Scholar Junior 1 award from the Fonds de Recherche du Quebec - Santé (FRQS) (2012–2016), the New Investigator Salary Award from the CIHR (2017–2022) and the Clinical Research Scholar Senior award from the FRQS (2022–2025). W. Vermeulen, A.F. Theil, and A. Raams are supported by grants from European Research Council Advanced grant (340988) and Oncode Institute (partly financed by the Dutch Cancer Society). Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2022/10

Y1 - 2022/10

N2 - Cockayne syndrome is a rare inherited DNA repair multisystemic disorder. Here, we aim to raise awareness of the phenotypic resemblances between Cockayne syndrome and the neurodevelopmental disorder caused by pathogenic variants in MORC2, a gene also involved in DNA repair. Using exome sequencing, we identified a de novo pathogenic variant in MORC2 in our patient. Our patient’s phenotype was characterized by multiple features evocative of Cockayne syndrome. Based on our patient’s phenotype, in addition to the phenotypic description of patients with pathogenic variants in MORC2 reported in the literature, we suggest that pathogenic variants in this gene are associated with a Cockayne-like phenotype.

AB - Cockayne syndrome is a rare inherited DNA repair multisystemic disorder. Here, we aim to raise awareness of the phenotypic resemblances between Cockayne syndrome and the neurodevelopmental disorder caused by pathogenic variants in MORC2, a gene also involved in DNA repair. Using exome sequencing, we identified a de novo pathogenic variant in MORC2 in our patient. Our patient’s phenotype was characterized by multiple features evocative of Cockayne syndrome. Based on our patient’s phenotype, in addition to the phenotypic description of patients with pathogenic variants in MORC2 reported in the literature, we suggest that pathogenic variants in this gene are associated with a Cockayne-like phenotype.

UR - http://www.scopus.com/inward/record.url?scp=85135225790&partnerID=8YFLogxK

U2 - 10.1007/s10048-022-00697-2

DO - 10.1007/s10048-022-00697-2

M3 - Article

C2 - 35920923

AN - SCOPUS:85135225790

SN - 1364-6745

VL - 23

SP - 271

EP - 274

JO - Neurogenetics

JF - Neurogenetics

IS - 4

ER -

A Cockayne-like phenotype resulting from a de novo variant in MORC2: expanding the phenotype of MORC2-related disorders

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this